Solidus Biosciences Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Solidus Biosciences General Information

Description

Developer of a three-dimensional cell culture micro-array technology designed to provide the high-throughput screening of both compounds and their metabolites for toxicity. The company's technology uses a biocatalytic platform to profile chemical compound toxicity to enhance decision-making for supporting new product development in the pharmaceutical, biotechnology, cosmetics, and agrichemical industries, enabling researchers to improve the process of new drug development by getting proprietary decision-enabling technology to enhance drug safety, efficiency, cost and, thereby, productivity from investment in new drug research and development.

Contact Information

Formerly Known As
Solidus Networks
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 409 Illinois Street
  • Suite 2073
  • San Francisco, CA 94158-2509
  • United States
Primary Industry
Biotechnology
Other Industries
Business/Productivity Software
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 409 Illinois Street
  • Suite 2073
  • San Francisco, CA 94158-2509
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solidus Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Apr-2016 Completed Out of Business
6. Grant 01-Dec-2012 Completed Generating Revenue
5. Grant 01-Jan-2008 Completed Generating Revenue
4. Grant 01-Jan-2007 Completed Startup
3. Grant 26-Dec-2005 Completed Startup
2. Early Stage VC Completed Startup
1. University Spin-Out 01-Jan-2005 Completed Startup
To view Solidus Biosciences’s complete valuation and funding history, request access »

Solidus Biosciences Patents

Solidus Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3976806-A1 Recombinant herpesvirales vector Inactive 30-May-2019
EP-3893940-A1 Combination therapy for treating muscular dystrophy Inactive 12-Dec-2018
EP-3893940-A4 Combination therapy for treating muscular dystrophy Inactive 12-Dec-2018
US-20140154722-A1 Apparatus for analyzing biomaterial Inactive 12-Aug-2011
WO-2013025542-A1 Apparatus for analyzing biomaterial Inactive 12-Aug-2011 C12M23/12
To view Solidus Biosciences’s complete patent history, request access »

Solidus Biosciences FAQs

  • When was Solidus Biosciences founded?

    Solidus Biosciences was founded in 2005.

  • Where is Solidus Biosciences headquartered?

    Solidus Biosciences is headquartered in San Francisco, CA.

  • What industry is Solidus Biosciences in?

    Solidus Biosciences’s primary industry is Biotechnology.

  • Is Solidus Biosciences a private or public company?

    Solidus Biosciences is a Private company.

  • What is Solidus Biosciences’s current revenue?

    The current revenue for Solidus Biosciences is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process